Moreover, bariatric and metabolic surgery are interventions with additional proven insulin-sensitizing effects [53,54] that reduce the detrimental signaling effects of the insulin/IGF1 axis, thereby exerting a positive impact on the incidence of cancer. This evidence concerns the gene IGF1 and cancer.